A detailed history of Aureus Asset Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Aureus Asset Management, LLC holds 1,929 shares of NVS stock, worth $189,717. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,929
Holding current value
$189,717
% of portfolio
0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$106.13 - $120.89 $204,724 - $233,196
1,929 New
1,929 $221,000
Q1 2021

May 14, 2021

SELL
$83.5 - $98.47 $302,186 - $356,362
-3,619 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$78.07 - $94.43 $312 - $377
4 Added 0.11%
3,619 $342,000
Q3 2020

Nov 13, 2020

SELL
$82.14 - $91.0 $22,095 - $24,479
-269 Reduced 6.93%
3,615 $314,000
Q2 2020

Aug 11, 2020

BUY
$80.93 - $91.1 $8,335 - $9,383
103 Added 2.72%
3,884 $339,000
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $7,985 - $11,188
-113 Reduced 2.9%
3,781 $312,000
Q4 2019

Feb 12, 2020

BUY
$84.35 - $95.37 $4,976 - $5,626
59 Added 1.54%
3,894 $369,000
Q3 2019

Nov 12, 2019

SELL
$85.54 - $94.26 $25,662 - $28,278
-300 Reduced 7.26%
3,835 $333,000
Q2 2019

Aug 14, 2019

BUY
$75.4 - $92.8 $8,972 - $11,043
119 Added 2.96%
4,135 $378,000
Q1 2019

May 13, 2019

BUY
$75.32 - $86.15 $376 - $430
5 Added 0.12%
4,016 $386,000
Q4 2018

Feb 13, 2019

SELL
$73.66 - $82.02 $28,801 - $32,069
-391 Reduced 8.88%
4,011 $344,000
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $55,894 - $64,654
-835 Reduced 15.94%
4,402 $379,000
Q2 2018

Aug 13, 2018

BUY
$64.91 - $73.36 $5,906 - $6,675
91 Added 1.77%
5,237 $396,000
Q1 2018

May 15, 2018

BUY
$70.39 - $84.15 $19,005 - $22,720
270 Added 5.54%
5,146 $416,000
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $3,616 - $3,882
50 Added 1.04%
4,876 $409,000
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $357,799 - $372,905
4,826
4,826 $414,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Aureus Asset Management, LLC Portfolio

Follow Aureus Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aureus Asset Management, LLC with notifications on news.